ヒト由来培養がん細胞を用いた薬物代謝酵素シトクロムP-450分子種等の変動要因に関する研究~エピジェネティクス関連事象や細胞の三次元的培養環境を中心に~
Author:
Open Access
- 1 December 2023
- journal article
- review article
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 143 (12) , 1013-1025
Abstract
Since commencing my role as a professor in a newly established Department of Pharmacodynamics and Molecular Genetics at the School of Pharmacy, Iwate Medical University, on April 1, 2007, my research has focused on modifying gene expression of cytochrome P-450 (CYP) in established human colon cancer cells. Additionally, I have been investigating methods to enhance the anti-tumor effects of irinotecan (CPT-11) and 5-fluorouracil (5-FU) using epigenetic modifying inhibitors of DNA methyltransferase and histone deacetylase. Treating colon cancer cells with a DNA methyltransferase inhibitor, 5-aza-2′-deoxycytidine (DAC), led to elevated expression levels of CYP1B1 and CYP3A4 through demethylation of the promoter regions of related genes. Furthermore, the administration of DAC and the histone deacetylase inhibitor depsipeptide [(DEP), an anti-cancer drug romidepsin] significantly increased the cellular sensitivities of human colon cancer cells to CPT-11 and 5-FU, respectively. Remarkably, DAC treatment also increased colon cancer cell sensitivity to SN-38, an active metabolite of CPT-11, through the suppression of the anti-apoptotic protein Bcl-2. DEP increased colon cancer cell sensitivity to 5-FU in association with increased expressions of tumor-suppressor p21 and major histocompatibility complex class II genes. Another facet of my research is centered around understanding the gene regulatory mechanisms of the CYP1 family through aryl hydrocarbon receptors (AhR)s under glucose-deprivation stress and in three-dimensional (3D) culture systems of human solid tumor cells. In the 3D culture of human liver cancer cells, I found Pregnane X Receptor being implicated in the regulation of CYP1A2, which aligns with the in vivo mode of CYP1A2 expression.Keywords
This publication has 20 references indexed in Scilit:
- An aryl hydrocarbon receptor induces VEGF expression through ATF4 under glucose deprivation in HepG2BMC Molecular Biology, 2013
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptorNature, 2011
- Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cellsBMC Cancer, 2011
- Analysis of humanCYP1A1andCYP1A2genes and their shared bidirectional promoter in eight world populationsHuman Mutation, 2009
- Global gene expression changes including drug metabolism and disposition induced by three-dimensional culture of HepG2 cells-Involvement of microtubulesBiochemical and Biophysical Research Communications, 2009
- Gene expression property of high-density three-dimensional tissue of HepG2 cells formed in radial-flow bioreactorJournal of Bioscience and Bioengineering, 2006
- Three-dimensional high-density culture of HepG2 cells in a 5-ml radial-flow bioreactor for construction of artificial liverJournal of Bioscience and Bioengineering, 2005
- HLA-DR signaling inhibits Fas-mediated apoptosis in A375 melanoma cellsExperimental Cell Research, 2004
- Biological effects of γ‐interferon on human tumor cells: Quantity and affinity of cell membrane receptors for γ‐IFN in relation to growth inhibition and induction of HLA‐DR expressionInternational Journal of Cancer, 1985
- N-hydroxylation of carcinogenic and mutagenic aromatic amines.Environmental Health Perspectives, 1983